title: Cervical screening. Rate of diagnosis of cytological abnormalities is best end point.
authors.forename: S
authors.initials: S
authors.lastname: Williamson
authors.forename: V
authors.initials: V
authors.lastname: Wadehra
mesh_terms: D001706:Biopsy; D005260:Female; D006801:Humans; D008403:Mass Screening; D015201:Meta-Analysis as Topic; D016032:Randomized Controlled Trials as Topic; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control*; D014626:Vaginal Smears